Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil a subgroup analysis of a phase 4 prospective study

Nadia E Aikawa Leonard de Vinci Kanda Kupa; Sandra Gofinet Pasoto; Samuel Katsuyuki Shinjo; Rosa Maria Rodrigues Pereira; Ana Marli Christovam Sartori; Alberto José da Silva Duarte; Leila Antonangelo; Ester Cerdeira Sabino; Paulo Rossi Menezes; Esper Georges Kallas; Clovis Artur Almeida da Silva; Eloisa Silva Dutra de Oliveira Bonfa

Lancet rheumatology v. 4, n. 2, p. E113-E124, 2022

Amsterdam 2022

Online access. The library also has physical copies.